Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.
An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain
Improving the NHS Blood Culture Pathway in England
Bloodstream infections (BSI) are common and cause severe disease and death. Blood cultures are used to identify whether patients have a bacterial or fungal BSI and assess whether the microbe will be resistant to any antimicrobial therapies (AMTs) helping clinicians to prescribe AMTs to patients who truly need them. NHS England’s blood culture audit indicated low adherence to best practice guidelines and trusts have raised concerns regarding the resource implications of achieving compliance.
Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling
The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor
Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland
Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
